David Toung
Stock Analyst at Argus Research
(3.32)
# 993
Out of 4,944 analysts
124
Total ratings
62.5%
Success rate
9.32%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Downgrades: Hold | n/a | $294.43 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $33.46 | +55.41% | 1 | Jul 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $484.79 | -3.05% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $271.81 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $14.12 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $201.47 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $148.12 | -15.61% | 9 | Sep 11, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $155.00 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $289.33 | +17.51% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $663.17 | +1.03% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $103.22 | +45.32% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $660.49 | +27.18% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $68.98 | +37.72% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $75.33 | +46.02% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $272.54 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.16 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $281.99 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $378.95 | -18.20% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $390.46 | -20.61% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $482.35 | -33.66% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $129.40 | +4.33% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $120.14 | -37.57% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $47.85 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $82.71 | +32.99% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $92.91 | +77.59% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.44 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $54.71 | +123.91% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $77.94 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $121.20 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $174.42 | -11.13% | 4 | Mar 27, 2020 |
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $294.43
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $33.46
Upside: +55.41%
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $484.79
Upside: -3.05%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $271.81
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $14.12
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $201.47
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $148.12
Upside: -15.61%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $155.00
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $289.33
Upside: +17.51%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $663.17
Upside: +1.03%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $103.22
Upside: +45.32%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $660.49
Upside: +27.18%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $68.98
Upside: +37.72%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $75.33
Upside: +46.02%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $272.54
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $25.16
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $281.99
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $378.95
Upside: -18.20%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $390.46
Upside: -20.61%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $482.35
Upside: -33.66%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $129.40
Upside: +4.33%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $120.14
Upside: -37.57%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $47.85
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $82.71
Upside: +32.99%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $92.91
Upside: +77.59%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.44
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $54.71
Upside: +123.91%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $77.94
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $121.20
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $174.42
Upside: -11.13%